ROSE

ZUR ROSE GROUP N

Stock SIX Swiss Exchange – Stock Market Prices, News & Analysis

Swiss company specializing in the online sale and distribution of pharmaceutical products.

Fr. 35.02
382.70 %

ZUR ROSE GROUP N

Fr. 35.02
382.70 %
ROSE

Swiss company specializing in the online sale and distribution of pharmaceutical products.

Price history of ZUR ROSE GROUP N
Price history of ZUR ROSE GROUP N

Performance & Momentum

6 Months 7.13 %
1 Year 66.70 %
3 Years 82.58 %
5 Years 98.08 %

Strategic Analysis

ZUR ROSE GROUP N • 2026

Zur Rose Group positions itself as a key player in online pharmacy in Europe, combining drug distribution and digital health solutions. Its model capitalizes on the growing digitalization of the pharmaceutical sector, aiming to simplify access to health products through integrated platforms.

Strengths
  • Recognized expertise in online pharmaceutical distribution in Europe
  • Advanced integration of digital services into the customer experience
  • Positioning in a growing market related to e-health
Weaknesses
  • Significantly deteriorated stock performance over the long term, reflecting structural difficulties
  • Recent lack of positive catalysts and neutral momentum
Momentum

The momentum of the stock is currently neutralized after a prolonged period of significant decline. This stagnation reflects an absence of recent favorable impulses, indicating a high risk and necessitating caution for investors seeking a tangible recovery.

Similar stocks to ZUR ROSE GROUP N

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone